A breakthrough in cell research may pave the way for treatments which stop cancer spreading through the body.
Scientists at British universities have worked out for the first time how cells are able to migrate from organ to organ.
The new research, spearheaded by biologists at University College London, could transform the way cancer is treated.
Crucially, the discovery has enabled scientists to work out how to block the movement of cells.
It means that aggressive cancer, which can quickly advance away from a primary tumour, might in the future be effectively frozen and isolated as soon as it is detected.
Most cancer deaths are not caused by initial tumours, but by secondary tumours in vital organs such as the lungs or brain that are created by cancerous cells invading other places in the body.
If the research can be used to develop an effective treatment it could save millions of lives each year.
Professor Roberto Mayor, whose paper was published today in the Journal of Cell Biology, said: ‘This is an important breakthrough in the understanding of how cells move, which we strongly believe provides an insight into the way cancer spreads.
Read more . . .
The Latest on: Stopping cancer from spreading
[google_news title=”” keyword=”Stopping cancer from spreading” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stopping cancer from spreading
- Is India becoming the cancer capital of the world?on May 10, 2024 at 12:01 am
Rising cancer cases in India, especially among children, highlight the urgent need for preventive measures and improved healthcare access.
- I’ve spent £54k on sunbeds, even when I lived in hostels – my cancer scare didn’t stop me, says Aisleyne Horgan-Wallaceon May 8, 2024 at 12:28 pm
AS she reclines on a sunbed at her favourite tanning salon, Aisleyne Horgan-Wallace lets out a satisfied sigh of relief. Not only is she giving her tan a welcome top-up, she’s also “high” on the ...
- Cancer Cells Spread When They Stop Recycling Wasteon May 7, 2024 at 5:00 pm
In their absence, tumor cells spread to the lung, an organ to which this cancer type doesn’t typically venture. The gene that codes for p47 protein produced the biggest difference when depleted, ...
- Altru Cancer Center Seeks Patients for Lung Cancer Vaccine Clinical Trialon May 7, 2024 at 9:00 am
Altru Cancer Center is seeking patients for a clinical trial for CurativeStage Non-Small Cell Lung Cancer (NSCLC). The clinical trial is investigating whether a combination of drugs and experimental ...
- How the drug abemaciclib treats breast canceron May 7, 2024 at 8:27 am
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
- Stopping blood canceron May 6, 2024 at 10:46 pm
The MHH joint project TARGET-MPN is investigating why the disease persists and progresses in malignant bone marrow diseases from the group of myeloproliferative neoplasms despite targeted treatment.
- Roving blood cells that ‘hunt and wipe out’ cancer could stop disease spreadingon May 2, 2024 at 7:20 am
ROVING white blood cells that hunt down cancer in different parts of the body could hold the key to tackling spreading tumours. A study of breast cancer patients found that some of the immune ...
- GV spinout launches with $67M, counterintuitive idea to ‘overactivate’ canceron May 2, 2024 at 4:00 am
A new Cambridge biotech incubated at GV (Google Ventures) has launched with a $67 million Series A funding and a new — perhaps even counterintuitive — approach to cancer treatment.
- Task force updates guidance for breast cancer screenings for women 40 and olderon May 1, 2024 at 8:13 pm
Women are now advised to get a mammogram every other year starting at age 40 and until age 74, according to new recommendations from the US Preventative Services Task Force.
- Breast cancer medication added to PBSon April 28, 2024 at 8:57 am
A new drug has been added to the Pharmaceutical Benefits Scheme which can help stop breast cancer from spreading. Abemaciclib works by blocking specific overactive proteins which signal cancer ...
via Bing News